Jean-Stephane Giraud

5PUBLICATIONS
17CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2026
Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center.

Jean-Stéphane Giraud, Sarah Watson, Alexandre Acramel

|Feb 18, 2026
Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacists.

Jean-Stéphane Giraud, Mélanie Brun, Romain Desmaris

|Oct 14, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort study.

Germain Perrin, Audrey Thomas-Schoemann, François Goldwasser

|Feb 10, 2024
NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients.

Jean-Stéphane Giraud, Anne Jouinot, Eric Pasmant

|Sep 25, 2020
De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on generics.

Jean-Stephane Giraud, Melanie Doisne, Aurelie Chan Hew Wai

Pageof 1

Frequent Collaborators

1 joint publications

Camille Tlemsani

1 joint publications

Germain Perrin

1 joint publications

Audrey Thomas-Schoemann

1 joint publications

François Goldwasser